Durvalumab Intravenous and Recombinate
Determining the interaction of Durvalumab Intravenous and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: durvalumab
Brand name: Imfinzi
Synonyms: Durvalumab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durvalumab Intravenous-Recombinate recombinant
- Durvalumab Intravenous-Recombivax
- Durvalumab Intravenous-Recombivax HB
- Durvalumab Intravenous-Recombivax HB Adult
- Durvalumab Intravenous-Recombivax HB Dialysis Formulation
- Durvalumab Intravenous-Recombivax HB Pediatric/Adolescent
- Recombinate-Dutasteride
- Recombinate-Dutasteride and tamsulosin
- Recombinate-Dutasteride and Tamsulosin Capsules
- Recombinate-Dutasteride Capsules
- Recombinate-Dutoprol
- Recombinate-Duvelisib